Article citationsMore>>

T. Kumamoto, M. Fujii and D. Hou, “Myricetin Directly Targets JAK1 to Inhibit Cell Transformation,” Cancer Letters, Vol. 275, No. 1, 2009, pp. 17-26. doi:10.1016/j.canlet.2008.09.027

has been cited by the following article:

• TITLE: Jamun (Syzygium cumini (L.)): A Review of Its Food and Medicinal Uses

  AUTHORS: Shrikant Baslingappa Swami, Nayan Singh J. Thakor, Meghatai M. Patil, Parag M. Haldankar

  KEYWORDS: Jamun-Syzygium cumini; Chemopreventive; Radioprotective; Antineoplastic Activities

  JOURNAL NAME: Food and Nutrition Sciences, Vol.3 No.8, August 8, 2012

  ABSTRACT: Eugenia jambolana Lam., commonly known as black plum or “jamun” is an important medicinal plant in various traditional systems of medicine. It is effective in the treatment of diabetes mellitus, inflammation, ulcers and diarrhea and preclinical studies have also shown it to possess chemopreventive, radioprotective and antineoplastic properties. The plant is rich in compounds containing anthocyanins, glucoside, ellagic acid, isoquercetin, kaemferol and myrecetin. The seeds are claimed to contain alkaloid, jambosine, and glycoside jambolin or antimellin, which halts the diastatic conversion of starch into sugar. The present review has been primed to describe the existing data on the information on traditional and medicinal use.